Altium Capital Management LLC / ARWR
Altium Capital Management LLC’s Arrowhead Pharmaceuticals In Position
Does Altium Capital Management LLC own Arrowhead Pharmaceuticals In (ARWR)? Not currently — the last reported position was 230.3K shares worth $4M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q4 2024
Shares
230.3K
% of Portfolio
+1.23%
Quarters Held
2
position exited
Position History ARWR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ARWR.